A device that could potentially allow blind people — even those born without the sense of sight — to see has received the U.S. Food and Drug Administration’s “breakthrough device ...
BridgeBio said it received breakthrough therapy designation from the U.S. Food and Drug Administration for infigratinib, a treatment under development for children with achondroplasia. The ...
Some results have been hidden because they may be inaccessible to you